Sanford C. Bernstein Lowers Agilent Technologies (NYSE:A) Price Target to $135.00

Agilent Technologies (NYSE:A) had its price objective lowered by Sanford C. Bernstein from $140.00 to $135.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm currently has a “market perform” rating on the medical research company’s stock. Sanford C. Bernstein’s price objective would indicate a potential upside of 1.89% from the stock’s previous close.

Several other equities research analysts have also recently weighed in on A. Citigroup lifted their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Bank of America lifted their price target on shares of Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Wells Fargo & Company began coverage on shares of Agilent Technologies in a report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price objective for the company. Stifel Nicolaus reaffirmed a “buy” rating and set a $151.00 target price on shares of Agilent Technologies in a research note on Monday, August 26th. Finally, UBS Group increased their price target on shares of Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $144.07.

Agilent Technologies Trading Down 1.5 %

Shares of A traded down $1.99 during trading hours on Tuesday, hitting $132.50. The company had a trading volume of 1,724,566 shares, compared to its average volume of 1,720,135. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36. Agilent Technologies has a 52-week low of $124.10 and a 52-week high of $155.35. The stock’s 50 day moving average price is $137.82 and its 200 day moving average price is $137.54. The firm has a market cap of $38.07 billion, a P/E ratio of 27.62, a P/E/G ratio of 5.89 and a beta of 1.07.

Insider Transactions at Agilent Technologies

In related news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. This trade represents a 19.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Hedge Funds Weigh In On Agilent Technologies

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Crewe Advisors LLC raised its stake in Agilent Technologies by 114.8% during the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after buying an additional 101 shares during the last quarter. Livelsberger Financial Advisory bought a new stake in shares of Agilent Technologies in the third quarter worth $28,000. Ridgewood Investments LLC purchased a new stake in Agilent Technologies during the second quarter valued at $29,000. Ashton Thomas Securities LLC bought a new position in Agilent Technologies in the third quarter valued at about $31,000. Finally, Fortitude Family Office LLC boosted its position in Agilent Technologies by 68.3% in the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock worth $35,000 after purchasing an additional 95 shares during the last quarter.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.